The short answer
Dried cinnamon has not been shown to change alogliptin absorption or effectiveness. A Ceylon-cinnamon extract trial does not establish the same effect for dried bark or this exact drug combination.
What this answer covers
Cinnamon Dry with Ceylon-cinnamon naming; Cinnamomum zeylanicum extract differs from dried bark and from cassia species.
- Supplement or preparation
- Cinnamon Dry
- Medication ingredient
- alogliptin
A recent trial studied an extract
A randomized Ceylon-cinnamon trial reported improvements in glucose measures with specific extract doses over four months. It did not verify an alogliptin subgroup in the abstract.
The preparation matters
An extract dose cannot be converted directly into an amount of dried cinnamon. Results should not be transferred between Ceylon and cassia products merely because both are sold as cinnamon.
No alogliptin drug-level result is available
The trial assessed diabetes measures, not alogliptin absorption or exposure. It therefore cannot establish that cinnamon strengthens or weakens alogliptin treatment.
Review the product and glucose response
Discuss starting or stopping the supplement with the diabetes team, and follow the prescribed monitoring plan. Do not change alogliptin yourself or assume a short spacing gap prevents a glucose effect. Kidney function, rather than a botanical enzyme theory alone, is central to its dosing.
Evidence and practical considerations
Absorption & effectiveness
No verified exact alogliptin clinical interaction. Original botanical preparations, other treatment regimens and null findings cannot establish the stated exposure/effectiveness or hypoglycemia claim.
- Exact scope
- Cinnamon Dry with Ceylon-cinnamon naming; Cinnamomum zeylanicum extract differs from dried bark and from cassia species. with Oral alogliptin RxCUI 1368001 IN supplied as benzoate; limited metabolism and renal elimination retained.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured event rate, imported CYP effect size or arbitrary dose adjustment.
Factors that may matter: Preparation; Kidney function; Other glucose-lowering medicines.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral alogliptin
DPP-4 inhibition produces glucose-dependent effects. Most dose is excreted unchanged in urine; CYP metabolism is limited. With or without food. Hypoglycemia precautions especially with insulin/secretagogues; renal function determines dosing.
How this applies: Exact alogliptin active-moiety bridge from current benzoate tablet label.
Not metformin/pioglitazone combination products. No exact botanical interaction rate or automatic nutrient requirement. Limited CYP role precludes simple probe-drug transfer.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 329 treatment-naive type 2 diabetes participants.
Alogliptin improved glycemic control; hypoglycemia and overall adverse-event proportions were similar across active and placebo groups.
How this applies: Exact alogliptin relevance limited by original exposure and endpoint.
Monotherapy does not establish supplement co-use safety or zero hypoglycemia.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 210 randomized people with type 2 diabetes, 186 completed.
Ceylon-cinnamon extract groups improved glucose measures from baseline; regression associated treatment with glucose/HbA1c changes.
How this applies: Exact alogliptin relevance limited by original exposure and endpoint.
No verified alogliptin subgroup, drug levels or exact-pair efficacy effect. Extract not plain dried bark; abstract does not supply a detailed adverse-event assessment.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact alogliptin article separating renal disposition, glucose effects and general husk timing. | |
| Research summary published |
Article revision: 160aed5ee062f2f8
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.